Biogen shares spike after FDA approves Alzheimer’s drug

About This Source - CNBC Television

CNBC is an American pay television business news channel, which primarily carries business day coverage of U.S. and international financial markets. Following the end of the business day and on non-trading days, CNBC primarily carries financial and business-themed documentaries and reality shows.

As of February 2015, CNBC is available to approximately 93,623,000 pay television households (80.4% of households with television) in the United States.

Recent from CNBC Television:

  • How to deal with ‘shrinkflation’
  • The 100th anniversary of insulin sees medicine not accessible for everyone
  • Top cyber officials testify on growing ransomware threat
  • CNBC Television published this video item, entitled “Biogen shares spike after FDA approves Alzheimer’s drug” – below is their description.

    Biogen shares spiked in Monday’s session after the FDA approved its controversial Alzheimer’s drug, which is the first new therapy for the disease in nearly two decades. CNBC’s Meg Tirrell reports.

    CNBC Television YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    Leave a Comment